Selarsdi
NDC 51759-607 · Teva Pharmaceuticals USA, Inc.
Generic nameustekinumab-aekn
Dosage formINJECTION, SOLUTION
RouteSUBCUTANEOUS
Active ingredient(s)USTEKINUMAB-AEKN
Strength90 mg/mL
Pharmacologic classInterleukin-12 Antagonist [EPC], Interleukin-12 Antagonists [MoA], Interleukin-23 Antagonist [EPC], Interleukin-23 Antagonists [MoA]
Marketing categoryBLA
Packages
51759-607-32 — 1 TRAY in 1 CARTON (51759-607-32) / 1 SYRINGE, GLASS in 1 TRAY / 1 mL in 1 SYRINGE, GLASS
Billed under HCPCS
Q9998 — Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg Medicare Part B payment limit (ASP + 6%): $10.53
Related Codes
Same active ingredient
FDA lists these products with the same active ingredient.
51759-413 — ustekinumab-aekn, 51759-414 — ustekinumab-aekn, 51759-505 — ustekinumab-aekn, 51759-708 — ustekinumab-aekn, 51759-709 — ustekinumab-aekn, 51759-710 — ustekinumab-aekn